观察复方阿嗪米特肠溶片治疗消化不良的疗效和安全性  被引量:6

Observation of compound azintamide enteric-coated tablets in the treatment efficacy and safety of poor digestion

在线阅读下载全文

作  者:李丽[1] 

机构地区:[1]深圳市龙岗区横岗人民医院消化内科,518115

出  处:《中国实用医药》2013年第11期17-18,共2页China Practical Medicine

摘  要:目的通过临床分析,观察复方阿嗪米特肠溶片治疗消化不良的疗效和安全性。方法认真回顾分析我院在2011年11月至2012年11月所诊断的200例消化不良患者的临床资料。按照1:1的比例将他们分为实验组与对照组,实验组患者在餐后立即服用复方阿嗪米特肠溶片3片,3次/d,15d一个疗程,对照组患者用餐后立即服用安慰剂3片,3次/d,15d一个疗程。对两组患者治疗前后每天用餐情况进行评估,消化不良症状的积分以及副作用等。结果治疗一个疗程后,实验组患者的食欲明显提高,相比对照组,其差异具有统计学意义(P<0.05);实验组患者的消化不良症状的积分也明显低于对照组;对照组出现的腹泻、腹胀痛等不良反应也高于实验组。结论复方阿嗪米特肠溶片治疗消化不良患者能够取得比较好的效果,其副作用小,无严重不良反应,安全性高,值得临床推广应用。Objective Through the clinical analysis, observation of compound azintamide enteric-coated tablets in the treatment efficacy and safety of poor digestion. Methods The clinical data of 200 cases of se- rious review of patients with dyspepsia analysis to our hospital in 2011 November to 2012 November diagnosis to analyze. According to the ratio of 1:1 were divided into experimental group and control group, patients in the experimental group were immediately after a meal to take compound azintamide enteric-coated tablets 3 tablets, three times a day, 15 days for a course of treatment, patients in the control group immediately after the meal to placebo 3 tablet, three times a day, 15 days for a course of treatment. Assessment of the two groups before and after treatment every meal, integral dyspeptic symptoms and side effects. Results After a course of treatment, patients in the experimental group's appetite increased significantly, compared to the control group, the difference was statistically significant (P 〈 0.05 ) ; integral dyspeptic symptoms in experimental group were also significantly lower than the control group; control group had diarrhea, pain and other adverse reactions were also higher than the experimental group. Conclusion Compound azintamide enteric-coated tablets in the treatment of patients with dyspepsia can achieve good effect, little side effect, no serious adverse reactions, high security, is worthy of clinical application.

关 键 词:复方阿嗪米特肠溶片 消化不良 安全性 用餐情况 

分 类 号:R57[医药卫生—消化系统]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象